Arcturus Therapeutics In...

NASDAQ: ARCT · Real-Time Price · USD
12.77
0.86 (7.22%)
At close: Jun 06, 2025, 3:59 PM
12.81
0.31%
After-hours: Jun 06, 2025, 05:41 PM EDT

Arcturus Therapeutics Statistics

Share Statistics

Arcturus Therapeutics has 27.12M shares outstanding. The number of shares has increased by 0.7% in one year.

27.12M
0.7%
0.12%
98.49%
n/a
21
n/a

Short Selling Information

The latest short interest is 5.41M, so 19.96% of the outstanding shares have been sold short.

5.41M
19.96%
30.88%
11.82

Valuation Ratios

The PE ratio is -5.66 and the forward PE ratio is -3.97. Arcturus Therapeutics's PEG ratio is -0.03.

-5.66
-3.97
3.31
0.5
1.9
-7.59
-0.03
Financial Ratio History

Enterprise Valuation

Currently the Enterprise Value (EV) is not available for Arcturus Therapeutics.

n/a
n/a
n/a
n/a

Financial Position

The company has a current ratio of 4.67, with a Debt / Equity ratio of 0.12.

4.67
4.67
0.12
-0.37
-0.47
0

Financial Efficiency

Return on Equity is n/a and Return on Invested Capital is n/a.

n/a
n/a
n/a
$795,339.08
$-465,178.16
174
0.4
n/a

Taxes

-4K
0%

Stock Price Statistics

The stock price has increased by -59.87% in the last 52 weeks. The beta is 2.29, so Arcturus Therapeutics's price volatility has been higher than the market average.

2.29
-59.87%
11.48
16.5
54.97
449,069

Income Statement

In the last 12 months, Arcturus Therapeutics had revenue of 138.39M and earned -80.94M in profits. Earnings per share was -3.

138.39M
134.84M
-95.67M
-80.94M
-77.4M
-80.94M
-3
Full Income Statement

Balance Sheet

The company has 237.03M in cash and 28.55M in debt, giving a net cash position of 208.48M.

237.03M
28.55M
208.48M
-448.81M
331.79M
229.38M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -59.75M and capital expenditures -648K, giving a free cash flow of -60.4M.

-59.75M
-648K
-60.4M
-2.24
Full Cash Flow Statement

Margins

Gross margin is 97.44%, with operating and profit margins of -69.13% and -58.49%.

97.44%
-69.13%
-58.49%
-58.49%
-55.93%
-69.13%
-43.64%

Dividends & Yields

ARCT does not appear to pay any dividends at this time.

n/a
n/a
n/a
n/a
n/a
n/a
Dividend Details

Analyst Forecast

The average price target for ARCT is $52.5, which is 311.1% higher than the current price. The consensus rating is "Buy".

$52.5
311.1%
Buy
7
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

n/a
n/a
n/a
n/a

Stock Splits

The last stock split was on Nov 16, 2017. It was a backward split with a ratio of 1:7.

Nov 16, 2017
backward
1:7

Scores

0.61
2